VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers.
Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers. Br J Cancer. 2018 05; 118(11):1419-1424.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Albumins
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Deoxycytidine
Drug Administration Schedule
Female
Humans
Male
Maximum Tolerated Dose
Middle Aged
Neoplasms
Paclitaxel
Polymorphism, Genetic
Treatment Outcome
Vascular Endothelial Growth Factor A
Young Adult
authors with profiles
SIQING FU
LAUREN AVERETT BYERS
FUNDA MERIC-BERNSTAM
APOSTOLIA MARIA TSIMBERIDOU
DANIEL D KARP
DAVID SANGHYUN HONG
SHANNON NEVILLE WESTIN
SARINA ANNE PIHA-PAUL
YUANQING YE
AUNG NAING
VIVEK SUBBIAH
FILIP JANKU
SHUBHAM PANT